Importance An understanding of the incidence and outcomes ofClostridium difficileinfection
(CDI) in the United States can inform investments in prevention and treatment interventions …

Clostridioides difficile infections (CDIs), and particularly recurrent infections, cause a
significant burden on the health-care system. Bezlotoxumab is a new agent for the …

Objectives Clostridioides difficile is an important pathogen of healthcare-associated
gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) …

Clostridioides difficile infection (CDI) is associated with high mortality rates among patients
with chronic illnesses. We aimed to identify avoidable risk factors to reduce the mortality rate …

We aimed to describe the clinical presentation, treatment, outcome and report on factors
associated with mortality over a 90-day period in Clostridioides difficile infection (CDI) …

Abstract Background and Aim Clostridioides difficile infection (CDI) is the leading cause of
hospital acquired‐infectious diarrhea in the USA. In this study, we assess the prevalence …

Purpose Patients with cancer are vulnerable to Clostridioides difficile infection (CDI) due to
their disease, treatment and regular hospital contact, yet if CDI-recurrence is more common …

Structured summary Background Clostridioides difficile infection (CDI) increases the risk of
complications and mortality. We assessed the magnitude of these outcomes in a large …

Background Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but
are associated with immune-mediated diarrhea and colitis (IMDC). Clostridioides difficile …

Clostridium difficile infection (CDI) is one of the most common healthcare-associated
infections in the United States. Its incidence has been increasing in the recent years despite …